Nimbolide

Solvents: water, good; alcohol, excellent; glycerin, fair to good; vinegar, poor; oil, excellent

Nimbolide is a naturally occurring compound derived from the neem tree (Azadirachta indica), which has been used in traditional medicine for centuries. This bioactive molecule has garnered significant attention in recent years due to its potential therapeutic properties, particularly in the fields of oncology, anti-inflammatory treatments, and antimicrobial applications.

Chemical Structure and Properties

Nimbolide is a limonoid, a class of tetranortriterpenoids, which are known for their diverse biological activities. The chemical structure of nimbolide is characterized by a furan ring, a lactone ring, and several hydroxyl groups. Its molecular formula is C27H30O7, and it has a molecular weight of approximately 466.52 g/mol. The presence of multiple functional groups in nimbolide contributes to its reactivity and interaction with various biological targets.

Biological Activities

Anticancer Properties

One of the most extensively studied aspects of nimbolide is its anticancer potential. Research has shown that nimbolide can induce apoptosis (programmed cell death) in various cancer cell lines, including breast, prostate, and pancreatic cancers. The mechanisms by which nimbolide exerts its anticancer effects include:

• Inhibition of cell proliferation
• Induction of oxidative stress
• Modulation of signaling pathways such as NF-κB and STAT3
• Suppression of angiogenesis (formation of new blood vessels)

These multifaceted actions make nimbolide a promising candidate for cancer therapy, either as a standalone treatment or in combination with other chemotherapeutic agents.

Anti-inflammatory Effects

Nimbolide has also demonstrated significant anti-inflammatory properties. It can inhibit the production of pro-inflammatory cytokines and enzymes, such as TNF-α, IL-6, and COX-2. By modulating the inflammatory response, nimbolide may be beneficial in treating chronic inflammatory conditions, including rheumatoid arthritis and inflammatory bowel disease.

Antimicrobial Activity

The antimicrobial properties of nimbolide have been explored against a range of pathogens, including bacteria, fungi, and viruses. Studies have shown that nimbolide can disrupt microbial cell membranes, inhibit biofilm formation, and interfere with microbial metabolism. These actions suggest that nimbolide could be developed as a natural antimicrobial agent, potentially addressing the growing issue of antibiotic resistance.

Potential Applications in Modern Medicine

Cancer Therapy

Given its potent anticancer properties, nimbolide is being investigated as a potential therapeutic agent in oncology. Preclinical studies have shown promising results, and there is ongoing research to evaluate its efficacy and safety in clinical trials. Nimbolide's ability to target multiple pathways involved in cancer progression makes it a versatile candidate for combination therapies.

Anti-inflammatory Treatments

Nimbolide's anti-inflammatory effects could be harnessed to develop new treatments for chronic inflammatory diseases. Its ability to modulate the immune response without causing significant side effects is particularly appealing. Further research is needed to fully understand its mechanisms and optimize its therapeutic potential.

Antimicrobial Agents

The rise of antibiotic-resistant pathogens has created an urgent need for new antimicrobial agents. Nimbolide's broad-spectrum antimicrobial activity positions it as a potential candidate for developing new treatments for infections. Its natural origin and low toxicity profile add to its appeal as an alternative to conventional antibiotics.

Challenges and Future Directions

While nimbolide shows great promise, several challenges need to be addressed before it can be widely used in clinical practice. These include:

• Optimization of its pharmacokinetic properties to improve bioavailability and stability
• Detailed understanding of its mechanisms of action
• Comprehensive evaluation of its safety and efficacy in clinical trials
• Development of efficient and sustainable methods for its extraction and synthesis

Future research should focus on overcoming these challenges and exploring the full therapeutic potential of nimbolide. Collaborative efforts between researchers, clinicians, and pharmaceutical companies will be crucial in translating the promising preclinical findings into effective treatments for patients.

Articles/Studies

Info at Biovision

Antibacterial

• In vitro antibacterial activity of nimbolide against Helicobacter pylori.
• Nimbolide attenuates complete Freund's adjuvant induced arthritis.

Antifibrotic

• Nimbolide as a potent anti-fibrotic agent.
• Nimbolide ameliorates unilateral ureteral obstruction-induced renal fibrosis.

Arthritis

Nimbolide exerts protective effects in complete Freund's adjuvant induced inflammatory arthritis.

Cancer

• Molecular targets of nimbolide for anti-cancer therapy.
• Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development
• Nimbolide is a promising candidate for the anticancer drug arsenal.
• Nanodelivery and anticancer effect of a limonoid, nimbolide, in breast and pancreatic cancer cells.
• Chemopreventive and therapeutic effects of nimbolide in cancer: The underlying mechanisms
• Harnessing the anti-cancer natural product nimbolide for targeted protein degradation A terpenoid lactone derived from Azadirachta indica (Neem tree) that displays a variety of biological activities including anti-malarial and anticancer activity. Recently it has also been shown that nimbolide sensitizes colon cancer cells to TRAIL-induced apoptosis through three distinct mechanisms: reactive oxygen species and ERK-mediated up-regulation of DR5 and DR4, downregulation of cell survival proteins, and up-regulation of pro-apoptotic proteins p53 and Bax.
• Nimbolide is a potential chemotherapeutic agent for **bladder cancer**.
• Nimbolide epigenetically regulates autophagy and apoptosis in **breast cancer**.
• Nimbolide inhibits angiogenesis in breast cancer.
• Involvement of actin cytoskeletal modifications in the inhibition of **triple-negative breast cancer** growth and metastasis by nimbolide.
• Nimbolide, a compound from Azadirachta indica (Neem), inhibits proliferation and induces programmed cell death in human **choriocarcinoma** cells.
• Nimbolide, a limonoid triterpene, inhibits growth of human **colorectal cancer** xenografts by suppressing the proinflammatory microenvironment.
• Nimbolide exhibits anticancer effect by reducing tumor size, tumor burden and by suppressing cell cycle progression in **liver cancer**.
• Nimbolide represents a novel therapeutic drug for hepatocellular carcinoma treatment.
• Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in **pancreatic cancer** cells.
• Nimbolide induces cell death in **T lymphoma** cells: Implication of altered apoptosis and glucose metabolism.
• The present investigation provides novel insights into molecular mechanisms of nimbolide inhibited T cell lymphoma progression.
• Co-treatment of Nimbolide augmented the anti-arthritic effects of methotrexate while protecting against organ toxicities.
• Nimbolide inhibits 2D and 3D prostate cancer cells migration, affects microtubules and angiogenesis.

Cardiovascular

Nimbolide prevents myocardial damage by regulating cardiac biomarkers, antioxidant level, and apoptosis signaling against doxorubicin-induced cardiotoxicity.

Diabetes

• Nimbolide protects the pregnant rats from GDM via alteration of inflammation, oxidative stress, and gut microbiota.
• Nimbolide ameliorates the streptozotocin-induced diabetic retinopathy.
• Nimbidiol ameliorates renal fibrosis and dysfunction in type-1 diabetes.

Hepatoprotective

Nimbolide attenuated the inflammation in the liver of autoimmune hepatitis's mice through regulation of HDAC3.

Pancreatitis

Nimbolide ameliorates pancreatic inflammation and apoptosis.

Psoriasis

Nimbolide has shown promising activity as an anti-psoriatic agent.

Other Effects

This study gives a proof of concept that encapsulation of nimbolide in PLGA nanoparticles increases its therapeutic effect on pancreatospheres.